Cargando…

Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series

BACKGROUND: To evaluate the association between various components of body composition and overall survival of patients treated with targeted therapies for advanced renal cell carcinoma. METHODS: This retrospective study included 124 Chinese patients with advanced renal cell carcinoma who had been t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Weijie, Zhu, Yao, Wang, Hongkai, Zhang, Hailiang, Shi, Guohai, Liu, Xiaohang, Ye, Dingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323238/ https://www.ncbi.nlm.nih.gov/pubmed/25668688 http://dx.doi.org/10.1371/journal.pone.0118022

Ejemplares similares

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
por: Gu, Weijie, et al.
Publicado: (2017)

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma
por: Wang, Beihe, et al.
Publicado: (2019)

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib
por: Lu, Xiaolin, et al.
Publicado: (2016)

Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma
por: Gu, Weijie, et al.
Publicado: (2015)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
por: Wu, Junlong, et al.
Publicado: (2017)

Fat Attenuation Index of Renal Cell Carcinoma Reveals Biological Characteristics and Survival Outcome
por: Wang, Hongkai, et al.
Publicado: (2022)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma
por: Lu, Xiaolin, et al.
Publicado: (2021)

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population
por: Qu, Yuanyuan, et al.
Publicado: (2016)

The Prognostic Value of Body Fat Components in Metastasis Renal Cell Carcinoma Patients Treated with TKIs
por: Dai, Jindong, et al.
Publicado: (2020)

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?
por: Zhang, Guiming, et al.
Publicado: (2014)

Adverse Effect of Lymph Node Dissection in Metastatic Renal Cell Cancer Patients Treated with Cytoreductive Nephrectomy: A Contemporary Analysis of Survival
por: Cao, Dalong, et al.
Publicado: (2019)

Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway
por: Wang, HongKai, et al.
Publicado: (2017)

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma
por: Zhang, Guiming, et al.
Publicado: (2015)

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
por: Xu, Wenhao, et al.
Publicado: (2021)

Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data
por: Tian, Xi, et al.
Publicado: (2020)

Age-Dependent Association between Sex and Renal Cell Carcinoma Mortality: a Population-Based Analysis
por: Qu, Yuanyuan, et al.
Publicado: (2015)

Real-world data on the efficacy and safety of pazopanib in IMDC favorable- and intermediate-risk metastatic renal cell carcinoma: a multicenter retrospective cohort study of Chinese patients
por: Anwaier, Aihetaimujiang, et al.
Publicado: (2022)

Complicated variation of simple renal cyst usually means malignancy: results from a cohort study
por: Qin, XiaoJian, et al.
Publicado: (2014)

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma
por: Fangning, Wan, et al.
Publicado: (2017)

Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2018)

Development and validation of a mitochondrial metabolism‐associated nomogram for prediction of prognosis in clear cell renal cell carcinoma
por: Zeng, Bohan, et al.
Publicado: (2020)

Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma
por: Xu, Wenhao, et al.
Publicado: (2022)

Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients
por: Jiangyi, Wang, et al.
Publicado: (2020)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Chang, Kun, et al.
Publicado: (2017)

Prognostic values of the core components of the mammalian circadian clock in prostate cancer
por: Yue, Wenchang, et al.
Publicado: (2021)

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2017)

The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab
por: Degens, Juliette H.R.J., et al.
Publicado: (2021)

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Su, Jiaqi, et al.
Publicado: (2022)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer
por: Bian, Xiaojie, et al.
Publicado: (2018)

AB032. Penile rehabilitation using Vacuum Erection Device for erectile dysfunction after radical prostatectomy
por: Ye, Dingwei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sq637vqlutjffte2neiq76n44k